Owkin signs AI drug discovery deal with Boehringer for cancer, immunology

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

marketsabout 2 hours ago

A ‘death cross’ is coming for the dollar. Why Trump will be happy.

Don’t look now, but there are some technical reasons to believe that U.S. Treasury Secretary Scott Bessent was right when he declared to the financial markets that “I am the house now.”

MarketWatch

marketsabout 2 hours ago

Microsoft’s stock has roared back to life, closing at its highest level of the year

Microsoft shares got off to a rough start this year, but investors have warmed to the company’s AI narrative over the last few months.

MarketWatch

marketsabout 3 hours ago

Apple’s expensive new iPhones could be a double-edged sword for the company

Bernstein analysts suggest Wall Street isn’t properly modeling the extent to which gross margins, a profit metric, could take a hit due to the rising costs of smartphone components.

MarketWatch